{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:58:44Z","timestamp":1784293124475,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.088","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T16:08:04Z","timestamp":1325606884000},"page":"1283-1290","source":"Crossref","is-referenced-by-count":51,"title":["Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity"],"prefix":"10.1016","volume":"30","author":[{"given":"Darwin","family":"S\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilia","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"O\u00f1ate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2011.12.088_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0010","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.micinf.2008.07.007","article-title":"Brucella: a Mr \u201cHide\u201d converted into Dr. Jekyll","volume":"10","author":"Gorvel","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0015","doi-asserted-by":"crossref","first-page":"12375","DOI":"10.1073\/pnas.192439399","article-title":"The two-component system BvrR\/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae","volume":"99","author":"Guzman-Verri","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.022622699","article-title":"Brucella melitensis: a nasty bug with hidden credentials for virulence","volume":"99","author":"Moreno","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2180-6-13","article-title":"Molecular targets for rapid identification of Brucella spp.","volume":"6","author":"Ratushna","year":"2006","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1369-5274(00)00165-X","article-title":"Brucellosis: a world-wide zoonosis","volume":"4","author":"Boschirolli","year":"2001","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0035","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/IAI.61.7.2841-2847.1993","article-title":"Cytokines response of T-cell subset from Brucella abortus-infected mice to soluble Brucella protein","volume":"61","author":"Zhan","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0040","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4049\/jimmunol.143.10.3330","article-title":"Temporal development of protective cell-mediated and humoral immunity in BALB\/c mice infected with Brucella abortus","volume":"143","author":"Araya","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0034-5288(18)32468-8","article-title":"Persistance of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses","volume":"31","author":"Corner","year":"1981","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/030098589603300607","article-title":"Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings","volume":"33","author":"Palmer","year":"1996","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0055","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","article-title":"Adverse events in humans associated with accidental exposure to the livestock brucellosis","volume":"22","author":"Ashford","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0060","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/IAI.68.6.3251-3260.2000","article-title":"Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis","volume":"68","author":"Gilbert","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0065","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/JB.182.8.2299-2306.2000","article-title":"Heterologous inducible expression of Enterococcus faecalis pCF10 aggregation substance Acs10 in Lactococcus lactis and Streptococcus gordonii contributes to cell hydrophobicity and adhesion to fibrin","volume":"182","author":"Hirt","year":"2000","journal-title":"J Bacterial"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2003-01-0110","article-title":"Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV envelopment","volume":"102","author":"Xin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0075","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.4049\/jimmunol.175.11.7297","article-title":"A novel mucosal vaccine base on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against Human Papillomavirus Type I6-induced tumors","volume":"175","author":"Berm\u00fadez-Humar\u00e1n","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and challenger","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0085","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2006.09.026","article-title":"Development of lactococcal GEM-based pneumococcal vaccines","volume":"25","author":"Audouy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1475-2859-7-24","article-title":"Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000","volume":"7","author":"Bahey-El-Din","year":"2008","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0095","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00253-005-0107-6","article-title":"10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis","volume":"68","author":"Mierau","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11259-010-9418-x","article-title":"Immune responses elicited in mice with recombinant Lactococcus lactis expressing F4 fimbrial adhesin FaeG by oral immunization","volume":"34","author":"Liu","year":"2010","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0105","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/AEM.61.7.2771-2774.1995","article-title":"Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract","volume":"61","author":"Klijn","year":"1995","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0110","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/S0264-410X(01)00119-0","article-title":"Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice","volume":"19","author":"Lee","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AEM.68.2.917-922.2002","article-title":"Production of human papillomavirus type 16 E7 protein in Lactococcus lactis","volume":"68","author":"Berm\u00fadez-Humar\u00e1n","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jgm.201","article-title":"Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo","volume":"3","author":"Lui","year":"2001","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0125","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1128\/AEM.67.4.1423-1428.2001","article-title":"Bovine rotavirus nonstructural protein 4 produce by Lactococcus lactis is antigenic and immunogenic","volume":"67","author":"Enouf","year":"2001","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20080601","article-title":"Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection","volume":"206","author":"Lee","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0135","first-page":"553","article-title":"Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B","volume":"48","author":"Barth","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/ar138","article-title":"Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis","volume":"3","author":"Hultgreen","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0145","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.168.11.5771","article-title":"The role IL-12 in maintaining resistance to Leishmania mayor","volume":"168","author":"Park","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0150","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/IAI.71.4.1887-1896.2003","article-title":"Intranasal Immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production","volume":"71","author":"Berm\u00fadez-Humar\u00e1n","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0155","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1128\/IAI.62.11.5201-5204.1994","article-title":"Subcloning and expression of the Brucella abortus L7\/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein","volume":"62","author":"Oliveira","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0160","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.68.6.3286-3289.2000","article-title":"Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S0100-879X1998000100010","article-title":"The role of T cell subset and cytokines in the regulation of intracellular bacterial infection","volume":"31","author":"Oliveira","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0170","first-page":"93","article-title":"18.5Kd protein. An interesting antigen of Brucella","volume":"27","author":"O\u00f1ate","year":"1995","journal-title":"Arch Med Vet"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0175","unstructured":"Bae J. Generation of baculovirus-Brucella abortus heat shock protein recombinants; mouse immune responses against the recombinants, and B. abortus superoxide dismutase and L7\/L12 recombinant proteins. Ph.D. Thesis. Virginia Polytechnic Institute and State University, Blacksburg; 1990."},{"key":"10.1016\/j.vaccine.2011.12.088_bib0180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0264-410X(94)90035-3","article-title":"Modulation of immune responses in BALB\/c mice vaccinated with Brucella abortus Cu\u2013Zn superoxide dismutase synthetic peptide vaccine","volume":"12","author":"Tabatabai","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0185","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/jb.175.18.5806-5813.1993","article-title":"Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis","volume":"175","author":"Langella","year":"1993","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51; a stable rough strain of Brucella abortus","volume":"28","author":"Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0195","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.67.2.986-988.1999","article-title":"Vaccination with live Escherichia coli expressing Brucella abortus Cu\/Zn superoxide dismutase protects mice against virulent B. abortus","volume":"67","author":"O\u00f1ate","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0200","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"O\u00f1ate","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1439-0450.2000.00402.x","article-title":"Frequent exposure of mice to crude Brucella abortus proteins down-regulates immune response","volume":"47","author":"O\u00f1ate","year":"2000","journal-title":"J Vet Med B"},{"issue":"44","key":"10.1016\/j.vaccine.2011.12.088_bib0210","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1016\/j.vaccine.2008.07.027","article-title":"Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2\/6 agonist MALP-2 as adjuvant","volume":"26","author":"Cataldi","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0891-5520(20)30344-5","article-title":"In defense of mucosal surface. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens","volume":"4","author":"McGhee","year":"1990","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-3659(00)00199-1","article-title":"Recent advances in mucosal vaccine development","volume":"67","author":"Chen","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00394-002-1105-4","article-title":"The role of the intestinal microflora for the development of the immune system in early childhood","volume":"41","author":"Ouwehand","year":"2002","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0230","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tibtech.2003.09.006","article-title":"Genetically modified probiotic in foods","volume":"21","author":"Ahmed","year":"2003","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0235","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2008.03.024","article-title":"Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis","volume":"26","author":"Yam","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2222.2005.02225.x","article-title":"Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization","volume":"35","author":"Adel-Patient","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0250","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1128\/JVI.74.14.6278-6286.2000","volume":"74","author":"Gherardi","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0255","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/eji.1830270820","article-title":"Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms","volume":"27","author":"Metzger","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0260","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2007.09.024","article-title":"Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1","volume":"25","author":"Cho","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0265","first-page":"708460","article-title":"Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production","author":"Li","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0270","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.micres.2010.02.002","article-title":"Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination","volume":"166","author":"Zhang","year":"2011","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host\u2013pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(00)01350-2","article-title":"Immunity and protection against Brucella abortus","volume":"3","author":"Golding","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0285","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/314996","article-title":"Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity","volume":"180","author":"Arulanandam","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0290","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/IAI.71.8.4780-4788.2003","article-title":"Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12","volume":"71","author":"Lynch","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0295","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1016\/j.vaccine.2006.04.033","article-title":"Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media","volume":"24","author":"Sabirov","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0300","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.4049\/jimmunol.161.10.5525","article-title":"IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells","volume":"161","author":"Buchanan","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0305","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0264-410X(00)00421-7","article-title":"IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines","volume":"19","author":"Buchanan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0310","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/IAI.69.11.6718-6724.2001","article-title":"Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection","volume":"69","author":"Arulanandam","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major","volume":"263","author":"Afonso","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0320","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.162.10.6141","article-title":"IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens","volume":"162","author":"Staats","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0325","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/IAI.73.6.3294-3300.2005","article-title":"An RNA vaccine based on recombinant Semliki Forest Virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB\/c mice","volume":"73","author":"Onate","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0330","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.vetmic.2007.11.015","article-title":"Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu\u2013Zn superoxide dismutase (SOD) gene in cattle","volume":"129","author":"Saez","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0335","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/j.vaccine.2011.04.088","article-title":"Co-immunization with interleukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu\u2013Zn superoxide dismutase protein against Brucella abortus","volume":"29","author":"Singha","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0340","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD and L7\/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL response","volume":"26","author":"Yu","year":"2007","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imbio.2005.09.004","article-title":"Evaluation of Brucella abortus DNA vaccine by expression of Cu\u2013Zn superoxide dismutase antigen fused to IL-2","volume":"211","author":"Gonzalez-Smith","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0350","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.micinf.2008.05.007","article-title":"Escheriosomes entrapped DNA vaccine co-expressing Cu\/Zn superoxide dismutase and IL-18 confers protection against Brucella abortus","volume":"10","author":"Singha","year":"2008","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2011.12.088_bib0355","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.vaccine.2011.02.054","article-title":"Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge","volume":"29","author":"Rajasekaran","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.088_bib0360","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T19:55:28Z","timestamp":1686599728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":72,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11020378"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.088","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}